|
DE431291C
(de)
|
1925-03-29 |
1926-07-08 |
Contessa Nettel A G |
Wechselkassette mit herausziehbarer Wechsellade
|
|
US1936364A
(en)
|
1930-08-22 |
1933-11-21 |
Pfizer Charles & Co |
Citrate solutions
|
|
US2260004A
(en)
|
1939-11-03 |
1941-10-21 |
Pfizer Charles & Co |
Stable soluble magnesium acid citrate
|
|
US2938891A
(en)
|
1956-03-30 |
1960-05-31 |
Roussel Uclaf |
Method of making oxytocin and intermediates thereof
|
|
US3076797A
(en)
|
1957-07-22 |
1963-02-05 |
Roussel Uclaf |
Process of producing oxytocin and intermediates obtained thereby
|
|
US4213968A
(en)
|
1978-06-05 |
1980-07-22 |
Coy David Howard |
Enkephalin derivatives
|
|
US4464378A
(en)
|
1981-04-28 |
1984-08-07 |
University Of Kentucky Research Foundation |
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
|
|
US4486441A
(en)
|
1982-12-03 |
1984-12-04 |
Merrell Toraude Et Compagnie |
Pseudotropyl halogeno-benzoates and their use in migraine treatment
|
|
JPS59163313A
(ja)
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
|
DE3686025T2
(de)
|
1985-05-22 |
1993-01-07 |
Liposome Technology Inc |
Verfahren und system zum einatmen von liposomen.
|
|
NL194729C
(nl)
|
1986-10-13 |
2003-01-07 |
Novartis Ag |
Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
|
|
ATE99543T1
(de)
|
1987-10-15 |
1994-01-15 |
Syntex Inc |
Pulverfoermige zubereitungen zur intranasalen verabreichung von polypeptiden.
|
|
US4885287A
(en)
|
1988-08-09 |
1989-12-05 |
University Of Kentucky Research Foundation |
Novel method of administering aspirin and dosage forms containing same
|
|
WO1991007947A1
(en)
|
1989-12-05 |
1991-06-13 |
Ramsey Foundation |
Neurologic agents for nasal administration to the brain
|
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
|
US6407061B1
(en)
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
|
US5460972A
(en)
|
1991-04-08 |
1995-10-24 |
Research Foundation Of The State University Of New York |
Ionized magnesium2+ concentrations in biological samples
|
|
GB9202464D0
(en)
|
1992-02-05 |
1992-03-18 |
Danbiosyst Uk |
Composition for nasal administration
|
|
GB9203769D0
(en)
|
1992-02-21 |
1992-04-08 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
GB9211268D0
(en)
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
|
SE9300937L
(sv)
|
1993-03-19 |
1994-09-20 |
Anne Fjellestad Paulsen |
Komposition för oral administrering av peptider
|
|
ATE204467T1
(de)
|
1993-04-22 |
2001-09-15 |
Emisphere Tech Inc |
Orale darreichungsform
|
|
US5482931A
(en)
|
1993-06-29 |
1996-01-09 |
Ferring Ab |
Stabilized pharmaceutical peptide compositions
|
|
US5837809A
(en)
|
1995-08-11 |
1998-11-17 |
Oregon Health Sciences University |
Mammalian opioid receptor ligand and uses
|
|
US6054462A
(en)
|
1994-04-13 |
2000-04-25 |
Janssen Pharmaceutica, N.V. |
Intranasal antimigraine compositions
|
|
JP3414539B2
(ja)
|
1994-05-11 |
2003-06-09 |
有限会社ドット |
経鼻吸収用組成物
|
|
WO1996020001A1
(en)
|
1994-12-28 |
1996-07-04 |
Teikoku Hormone Mfg. Co., Ltd. |
Transmucosal preparation
|
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
|
ATE247456T1
(de)
|
1996-02-27 |
2003-09-15 |
Teijin Ltd |
Puderförmige zusammensetzung zur nasalen anwendung
|
|
DE19627228A1
(de)
|
1996-07-05 |
1998-01-08 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5798266A
(en)
*
|
1996-08-27 |
1998-08-25 |
K-Quay Enterprises, Llc |
Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
|
|
US5855907A
(en)
|
1997-03-24 |
1999-01-05 |
Peyman; Gholam A. |
Method of treatment of migraine
|
|
SE9701161D0
(sv)
|
1997-03-27 |
1997-03-27 |
Karolinska Innovations Ab |
New use I
|
|
SE9701162D0
(sv)
|
1997-03-27 |
1997-03-27 |
Karolinska Innovations Ab |
New use II
|
|
WO1999003491A1
(en)
|
1997-07-15 |
1999-01-28 |
Novo Nordisk A/S |
New use of nociceptin
|
|
US6432986B2
(en)
|
1997-07-21 |
2002-08-13 |
Bruce H. Levin |
Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
|
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US6143278A
(en)
|
1998-02-23 |
2000-11-07 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
|
US6090368A
(en)
|
1998-03-03 |
2000-07-18 |
The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations |
Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
|
|
JP4394279B2
(ja)
|
1998-03-09 |
2010-01-06 |
ジーランド ファーマ アクティーゼルスカブ |
酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
|
|
US6068999A
(en)
|
1998-06-25 |
2000-05-30 |
Hendrix; Curt |
Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
|
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
|
ES2252993T3
(es)
|
1998-12-09 |
2006-05-16 |
Chiron Corporation |
Administracion de agentes neurotroficos al sistema nervioso central.
|
|
AU2173400A
(en)
|
1998-12-09 |
2000-06-26 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
|
US7273618B2
(en)
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
|
US6139861A
(en)
|
1999-01-14 |
2000-10-31 |
Friedman; Mark |
Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
|
|
HRP20010926A2
(en)
|
1999-06-16 |
2003-04-30 |
Nastech Pharmaceutical Co |
Pharmaceutical formulations and methods comprising intranasal morphine
|
|
JP2001002589A
(ja)
|
1999-06-18 |
2001-01-09 |
Teijin Ltd |
穏やかな薬物血中濃度の上昇を可能とする経鼻投与用組成物
|
|
JP2001089359A
(ja)
|
1999-09-24 |
2001-04-03 |
Toko Yakuhin Kogyo Kk |
鎮痛成分の点鼻用ゲルまたはゾル製剤
|
|
WO2001026642A2
(en)
|
1999-10-08 |
2001-04-19 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
AU1261501A
(en)
|
1999-12-06 |
2001-06-18 |
Stanley L. Gore |
Compositions and methods for intranasal delivery of active agents to the brain
|
|
EP1237567B1
(en)
|
1999-12-09 |
2005-08-03 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
|
NZ520015A
(en)
|
1999-12-16 |
2003-03-28 |
Dermatrends Inc |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6413499B1
(en)
|
2000-01-06 |
2002-07-02 |
Bryan M. Clay |
Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
|
|
US20070032410A1
(en)
|
2000-01-11 |
2007-02-08 |
Atossa Healthcare, Inc. |
Compositions and methods for the treatment of psychiatric disorders
|
|
JP2001233787A
(ja)
|
2000-02-04 |
2001-08-28 |
Patents Exploitation Co Bv |
小・中サイズのペプチド含有薬学的組成物
|
|
EP1121935B1
(en)
|
2000-02-04 |
2008-08-13 |
Patents Exploitation Company B.V. |
Pharmaceutical composition containing a small or medium size peptide
|
|
US7163921B1
(en)
|
2000-04-14 |
2007-01-16 |
Nippon Shinyaku Co., Ltd. |
Peptide derivatives and medicinal compositions
|
|
KR20030060771A
(ko)
|
2000-04-28 |
2003-07-16 |
메모리얼 슬로안-케터링 캔서 센터 |
국소용 마취제/아편양약물 제제 및 이들의 용도
|
|
US7084126B1
(en)
|
2000-05-01 |
2006-08-01 |
Healthpartners Research Foundation |
Methods and compositions for enhancing cellular function through protection of tissue components
|
|
AU2001262992A1
(en)
|
2000-05-10 |
2002-02-18 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of opioids
|
|
IL137820A
(en)
|
2000-08-10 |
2009-06-15 |
S I S Shulov Inst For Science |
Pharmaceutical composition for topical administration comprising an analgesic peptide
|
|
EP1370282A2
(en)
|
2000-10-13 |
2003-12-17 |
Chiron Corporation |
Method for treating ischemic events affecting the central nervous system
|
|
US20070112052A9
(en)
|
2001-01-05 |
2007-05-17 |
Larry Caldwell |
Methods and compositions for treating headache pain with topical NSAID compositions
|
|
AU2002305066B8
(en)
|
2001-03-23 |
2008-04-17 |
Albert Einstein College Of Medicine Of Yeshiva University |
Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside
|
|
US20020169102A1
(en)
|
2001-04-03 |
2002-11-14 |
Frey William H. |
Intranasal delivery of agents for regulating development of implanted cells in the CNS
|
|
WO2002086105A1
(en)
|
2001-04-20 |
2002-10-31 |
Chiron Corporation |
Delivery of polynucleotide agents to the central nervous sysstem
|
|
US7820688B2
(en)
|
2001-04-27 |
2010-10-26 |
Memorial Sloan-Kettering Cancer Center |
Topical anesthetic/opioid formulations and uses thereof
|
|
SE0102184D0
(sv)
|
2001-06-19 |
2001-06-19 |
Uvnaes Moberg Kerstin |
New subject-matter
|
|
IL161446A0
(en)
|
2001-11-26 |
2004-09-27 |
Daiichi Suntory Pharma Co Ltd |
Medicinal compositions for nasal absorption
|
|
US20030104085A1
(en)
|
2001-12-05 |
2003-06-05 |
Yeomans David C. |
Methods and compositions for treating back pain
|
|
EP1487474A4
(en)
|
2002-02-25 |
2006-11-29 |
Chiron Corp |
INTRANASAL ADMINISTRATION OF MC4-R AGONISTS
|
|
US7666876B2
(en)
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
|
US20040105889A1
(en)
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
AU2003234185C1
(en)
|
2002-04-22 |
2009-11-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide inhibitors of protein kinase C
|
|
GB0209494D0
(en)
|
2002-04-25 |
2002-06-05 |
Optinose As |
Nasal devices
|
|
EP1499888B1
(en)
|
2002-04-29 |
2010-07-07 |
Euro-Celtique S.A. |
Conformationally constrained peptides that bind the orl-1 receptor
|
|
AU2003229735A1
(en)
|
2002-05-02 |
2003-11-17 |
Bayer Aktiengesellschaft |
Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
|
|
WO2004006959A1
(en)
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
AU2003273247A1
(en)
|
2002-08-30 |
2004-03-19 |
Board Of Regents, The University Of Texas System |
Non-invasive methods to identify agents for treating pain
|
|
ITMI20022022A1
(it)
|
2002-09-24 |
2004-03-25 |
Girolamo Calo' |
Analoghi di nocicettina.
|
|
EP1556068B1
(en)
*
|
2002-10-03 |
2010-08-18 |
Neuropharmacology Services, LLC |
Oxytocin for use in the treatment of Autism and Asperger's disorder
|
|
WO2004062563A2
(en)
|
2003-01-16 |
2004-07-29 |
Université de Lausanne |
Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders
|
|
WO2004073646A2
(en)
|
2003-02-19 |
2004-09-02 |
University Of Rochester |
Treatment of pain through expression of opioid receptors
|
|
DE60323938D1
(de)
|
2003-03-27 |
2008-11-20 |
Pantarhei Bioscience Bv |
Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit
|
|
CA2520655A1
(en)
|
2003-04-08 |
2004-11-04 |
Biotempt, B.V. |
Compositions for mucosal and oral administration comprising hcg fragments
|
|
GB0319119D0
(en)
|
2003-08-14 |
2003-09-17 |
Optinose As |
Delivery devices
|
|
US20050153885A1
(en)
|
2003-10-08 |
2005-07-14 |
Yun Anthony J. |
Treatment of conditions through modulation of the autonomic nervous system
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
US20050228023A1
(en)
|
2003-12-19 |
2005-10-13 |
Sri International |
Agonist and antagonist ligands of the nociceptin receptor
|
|
US20080103209A1
(en)
|
2004-04-23 |
2008-05-01 |
The Regents Of The University Of California |
Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists
|
|
EP1604655A1
(en)
|
2004-06-09 |
2005-12-14 |
Schwarz Pharma Ag |
Novel use of peptide compounds for treating pain in trigeminal neuralgia
|
|
US7618615B2
(en)
|
2004-08-13 |
2009-11-17 |
Healthpartners Research Foundation |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
|
US7151084B2
(en)
|
2004-12-27 |
2006-12-19 |
Miller Landon C G |
Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes
|
|
PL1877073T3
(pl)
|
2004-12-01 |
2014-03-31 |
The Sec Dep For Health |
Niecytotoksyczne koniugaty białkowe
|
|
NZ581205A
(en)
|
2005-02-23 |
2011-06-30 |
Alza Corp |
Intranasal administration of active agents to the central nervous system
|
|
EP2455072A1
(en)
|
2005-03-11 |
2012-05-23 |
Endo Pharmaceuticals Solutions Inc. |
Controlled release formulations of octreotide
|
|
US20060252685A1
(en)
|
2005-05-04 |
2006-11-09 |
Gould Jeffrey D |
Treatment for sleep apnea
|
|
CA2620202C
(en)
|
2005-08-26 |
2016-10-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapy procedure for drug delivery for trigeminal pain
|
|
WO2008134071A1
(en)
|
2007-04-26 |
2008-11-06 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant extended release formulations
|
|
MX2008009125A
(es)
*
|
2006-01-18 |
2008-10-23 |
Qps Llc |
Composiciones farmaceuticas con estabilidad mejorada.
|
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
|
US9023793B2
(en)
|
2006-09-29 |
2015-05-05 |
Retrophin, Inc. |
Intranasal carbetocin formulations and methods for the treatment of autism
|
|
US8142803B2
(en)
|
2007-03-22 |
2012-03-27 |
Magceutics, Inc. |
Magnesium compositions and uses thereof for neurological disorders
|
|
CA2689476C
(en)
*
|
2007-06-07 |
2014-08-05 |
Nastech Pharmaceutical Company Inc. |
Intranasal carbetocin formulations and methods for the treatment of autism
|
|
EP2152240A4
(en)
|
2007-06-08 |
2012-05-09 |
Healthpartners Res Foundation |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
|
|
JP2009073744A
(ja)
|
2007-09-19 |
2009-04-09 |
Saitama Medical Univ |
片頭痛の予防治療剤
|
|
EP2161030A1
(en)
|
2008-09-09 |
2010-03-10 |
Rijksuniversiteit te Groningen |
Oxytocin formulations and uses thereof
|
|
JP5467785B2
(ja)
|
2009-03-25 |
2014-04-09 |
大塚製薬株式会社 |
抗鳥インフルエンザウイルス抗体の産生促進剤
|
|
SG10201406930UA
(en)
|
2009-07-27 |
2014-11-27 |
Nocicepta Llc |
Methods For Treatment Of Pain
|
|
JP5491119B2
(ja)
|
2009-10-02 |
2014-05-14 |
日東電工株式会社 |
薬物含有微粒子を含む医薬組成物およびその製造方法
|
|
US20130130985A1
(en)
|
2010-04-01 |
2013-05-23 |
Paul Alewood |
Oxytocin peptide analogues
|
|
WO2011146726A1
(en)
*
|
2010-05-19 |
2011-11-24 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders
|
|
US8921306B2
(en)
|
2010-06-07 |
2014-12-30 |
The University Of Queensland |
Nociceptin mimetics
|
|
WO2012016229A2
(en)
|
2010-07-30 |
2012-02-02 |
The Regents Of The University Of California |
Oxytocin treatment to improve memory and modify blood glucose
|
|
JO3400B1
(ar)
|
2010-09-30 |
2019-10-20 |
Ferring Bv |
مركب صيدلاني من كاربيتوسين
|
|
US20120252894A1
(en)
|
2011-04-01 |
2012-10-04 |
Giniatullin Rashid |
Compounds for alleviating pain and stress in fetus and newborn
|
|
SE536091C2
(sv)
|
2011-04-14 |
2013-04-30 |
Pep Tonic Medical Ab |
Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
|
|
US20140045702A1
(en)
*
|
2012-08-13 |
2014-02-13 |
Synapdx Corporation |
Systems and methods for distinguishing between autism spectrum disorders (asd) and non-asd development delay
|
|
EP2908840A1
(en)
|
2012-10-12 |
2015-08-26 |
Peptonic Medical AB |
Novel use of a composition comprising oxytocin
|
|
US20140147519A1
(en)
|
2012-11-26 |
2014-05-29 |
Larry A. MCPHAIL |
Migraine Treatment
|
|
EP2845850A1
(en)
*
|
2013-09-10 |
2015-03-11 |
ObsEva S.A. |
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
|
|
SG11201705591PA
(en)
|
2015-01-07 |
2017-08-30 |
Trigemina Inc |
Magnesium-containing oxytocin formulations and methods of use
|